Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-03

FDA Approved: ZIPRASIDONE MESYLATE — Original Application (STERISCIENCE SPECIALTIES PRIVATE LIMITED)

View source ↗

Summary

FDA approved an original application for ziprasidone mesylate from SterisScience Specialties Private Limited, enabling a generic version of the antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziprasidone mesylate (Ziprasidone mesylate)

Snippet

ORIG AP for ZIPRASIDONE MESYLATE (ZIPRASIDONE MESYLATE)